SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-186570
Filing Date
2023-07-13
Accepted
2023-07-13 16:15:59
Documents
13
Period of Report
2023-07-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d513208d8k.htm   iXBRL 8-K 39285
2 EX-99.1 d513208dex991.htm EX-99.1 22022
  Complete submission text file 0001193125-23-186570.txt   196178

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA meip-20230713.xsd EX-101.SCH 2857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20230713_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20230713_pre.xml EX-101.PRE 11266
7 EXTRACTED XBRL INSTANCE DOCUMENT d513208d8k_htm.xml XML 3341
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 231086930
SIC: 2834 Pharmaceutical Preparations